New Israeli sperm donor study raises potential concerns

A new study has been published in the peer-reviewed journal Andrology, reporting on pre- and post-vaccination sperm counts and quality in 37 sperm donors in Israel. There have long been concerns about the potential for the mRNA products to have deleterious effects on male fertility, particularly after frequent reports of female menstrual irregularities, and the (now widely accepted) confirmation that the Lipid-nanoparticles become distributed around the body.

Read More

The ONS Infection Survey: a re-evaluation of the data

Whether this is Omicron or cross reactivity with previously endemic coronaviruses is uncertain. What is clear from the Ct values in the ONS Infection Survey is that neither “non-pharmaceutical interventions” or vaccines have had any impact on waves of infectious SARS-CoV-2 carriers and that neither economically destructive lockdowns or mandating experimental vaccines should ever have been attempted.

Read More

Rise in long-term sickness

The ONS have published their survey data on the number of working aged people who are economically inactive. The levels are higher than in the past and many commentators were quick to blame the rise on long covid. It is worth looking a little more closely before jumping to that conclusion.

Read More

Lockdown Harms to children

From late 2020, the various harms of lockdowns, particularly for children, were becoming apparent, with acknowledgement from the DfE and OFSTED that all was not well.  Signs of deterioration in adolescent mental health and increase in domestic violence and child abuse were noted, as summarised by the HART team.

Read More

First finding from Pfizer trials

A texan court ordered that the FDA release the documents used by the FDA to give emergency use authorisation for the Pfizer vaccine. The FDA asked if these documents could be kept hidden until 2076 but by August all will have been shared. Early analysis has demonstrated several concerning anomalies but crucially it has revealed that the efficacy data was not what was sold.

Read More

Second Open Letter to all members of the FDA vaccines committee

We are a group of health professionals and scientists from the UK, who submitted a letter to the FDA meeting in March regarding our concerns over the potential authorisation of Pfizer vaccine for children aged 6 months to 4 years and our letter is reattached today in readiness for your June meeting.  No new evidence has come to light since our March letter, which gives any credibility to the necessity, safety or even efficacy of this vaccine for infants. 

Read More

The relaxation of the mask requirement in healthcare settings

On the 1st of June 2022, NHS England issued further guidance regarding the use of face masks in clinical settings. In what could be – optimistically – construed as further progress towards the Government’s ‘Living with covid’ goal, this latest official briefing directs hospitals and other care settings to end the requirement for staff, patients and visitors to wear face coverings in most wards and departments.

Read More

Lockdowns: the evidence revisited

In March 2021, we wrote two sections in ‘Covid-19 the evidence’, namely ‘Economic impacts – the true cost of lockdown’ and ‘Lockdowns – do they work?’.  Over a year later, we have revisited not only the financial costs of lockdowns but also the societal costs, the impact on healthcare and the lack of evidence for overall benefit. 

Read More